Eledon Pharmaceuticals (ELDN) Tax Provisions (2021)

Eledon Pharmaceuticals (ELDN) posted Tax Provisions of -$579000.0 for Q4 2021, up 15.6% on a QoQ basis from -$686000.0 in Q3 2021.

Eledon Pharmaceuticals (ELDN) Tax Provisions (2021) Analysis & Trends

Eledon Pharmaceuticals' Tax Provisions history runs 1 years deep, the most recent figure standing at -$579000.0 for Q4 2021.

Quarterly Tax Provisions changed N/A year-over-year to -$579000.0 in Q4 2021, while the trailing twelve-month figure through Dec 2021 was -$2.4 million (changed N/A YoY) and the FY2025 annual result came in at $35000.0, down 91.88% from the prior year.
Tax Provisions was -$579000.0 for Q4 2021 at Eledon Pharmaceuticals, up from -$686000.0 in the prior quarter.
Across five years, Tax Provisions topped out at -$501000.0 in Q1 2021 and bottomed at -$686000.0 in Q3 2021.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Taxes (Qtr)
1	Oculis Holding AG	68,785.72 Bn	68,785.72 Bn	-	125,146.46
2	Nanobiotix	1,895.57 Bn	1,895.51 Bn	-	-
3	BeOne Medicines	471.35 Bn	466.56 Bn	1.35 Bn	31.86 Mn
4	NuCana	279.75 Bn	279.75 Bn	-	188,883.60
5	Vertex Pharmaceuticals	120.24 Bn	113.00 Bn	2.59 Bn	221.50 Mn
6	Regeneron Pharmaceuticals	67.80 Bn	59.04 Bn	3.31 Bn	104.00 Mn
7	Belite Bio	62.51 Bn	62.51 Bn	-	-
8	Argenx Se	57.38 Bn	57.38 Bn	1.41 Bn	179.00 Mn
9	Revolution Medicines	37.78 Bn	37.78 Bn	-	-
10	Eledon Pharmaceuticals	5.43 Mn	-105.66 Mn	-	-

Download Data